---
title: >-
  Patterns of Remdesivir Initiation in Immunocompromised Patients Hospitalized
  With COVID-19
description: >-
  Explore this publication on real-world evidence: Patterns of Remdesivir
  Initiation in Immunocompromised Patients Hospitalized With COVID-19.
date: '2025-01-01'
category: Publications
tags:
  - COVID-19
  - Poster Presentation
  - Care
  - 'No'
  - Methods/Pharmacoepi
  - R&D
canonical_url: >-
  https://www.headwaterscience.com/resources/publications/di-covid-19/patterns-of-remdesivir-initiation-in-immunocompromised/
source: Headwater Science
license: © 2026 Headwater Science. All rights reserved.
slug: patterns-of-remdesivir-initiation-in-immunocompromised
id: 2cATFTLmnCSuuJ3eyvHNjr
contentType: article
---

## Challenge

Immunocompromised patients hospitalized with COVID-19 face heightened risk of disease progression but patterns of remdesivir initiation in this vulnerable subgroup had not been characterized in real-world US hospital data.

## Solution

Target RWE researchers analyzed hospital data to describe patterns of remdesivir initiation timing, dose, and duration among immunocompromised patients hospitalized with COVID-19.

## Impact

Characterizing remdesivir initiation patterns in immunocompromised COVID-19 patients provides Gilead with post-authorization effectiveness evidence for this high-risk subgroup and informs clinical guideline development.

## Use Cases / Links

Remdesivir initiation pattern characterization in immunocompromised COVID-19 patients for Gilead post-authorization strategy, Clinical guideline evidence supporting remdesivir use optimization in immunocompromised COVID-19 settings